- Issuer ticker
-
JAZZ
- Reported as of
-
04 Nov 2026
- Net transaction value
-
-$326,910
- SEC form
-
4
- Accepted by SEC
-
06 Nov 2026, 17:19:57 UTC
Filing notes and source
Key filing fact
Patricia Carr filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 06 Nov 2026.
Key facts
- This page summarizes Patricia Carr's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Nov 2026, 17:19.
Change
- Previous filing in this sequence was filed on 09 Mar 2026.
- Current net transaction value: -$326,910.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001784606
Primary reporting owner
Carr Patricia
- Relationship
-
SVP, Chief Accounting Officer
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
JAZZ
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +1,250
- Change %
- +19%
- Price
-
$140.03*
- Shares after
- 7,925
- Date
- 04 Nov 2026
- Ownership
- Direct
- Footnotes
- F1
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- -$289,212
- Shares
- -1,250
- Change %
- -16%
- Price
-
$231.37
- Shares after
- 6,675
- Date
- 04 Nov 2026
- Ownership
- Direct
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- -$37,697
- Shares
- -163
- Change %
- -2.4%
- Price
-
$231.27
- Shares after
- 6,512
- Date
- 04 Nov 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
JAZZ
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -1,250
- Change %
- -29%
- Price
-
$0.000000*
- Shares after
- 3,000
- Date
- 04 Nov 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 1,250
- Exercise price
- $140.03
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Explanation of responses
2 footnotes